02/23/2024 23:27:32
  • Home | The dengue dilemma
  • In this issue
  • Owen Mumford
  • Contents
  • Hapa Company Insight
  • Daiichi Jitsugyo
  • News
  • Embocaps
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • The pharma industry briefing
  • Dow Europe Company Insight
  • Gerteis Company Insight
  • Gerteis
  • The problem of manipulated data
  • Capsugel Company Insight
  • Capsugel
  • Timeline: the dengue vaccine dilemma
  • TSS Company Insight
  • TSS
  • From evergreening to thicketing: exploring manipulation of the pharma patent sys
  • Emirates SkyCargo
  • AtoZ-CRO Company Insight
  • AtoZ-CRO
  • A safer ride: the latest innovation in targeted cancer treatment
  • Swiss WorldCargo
  • Accurate Biometrics
  • Accurate Biometrics Company Insight
  • Nelson Labs
  • Treading the line: the challenge of transplant rejection drugs
  • Corbion Purac
  • Erdmann Design Company Insight
  • Erdmann Design Switzerland
  • Treating menopause: at last a non-hormonal alternative?
  • Yourway
  • ImmuMap Company Insight
  • ImmuMap
  • Drug repurposing: the industry’s all-rounder medicines
  • Fargo
  • Pharma Support Services Company Insight
  • Pharma Support Services
  • One step closer to a Chlamydia vaccine
  • Aralab
  • Synex Synthetics
  • Deals in brief powered by GlobalData
  • Charles Ischi
  • The key list powered by GlobalData
  • Pharmaceutical Solutions Industry
  • Clinichain Company Insight
  • Clinichain
  • Sanofi
  • Events
  • Nymi
  • Modality Solutions
  • Pfanstiehl
  • Next issue
  • Mimotopes
  • ICCI - International Cannabis and Cannabinoids Institute 
  • ICCI
10/29/2019 00:00:00